↓ Skip to main content

Racecadotril

Overview of attention for article published in Drugs, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs
1 blog
patent
7 patents
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
58 Mendeley
Title
Racecadotril
Published in
Drugs, November 2012
DOI 10.2165/00003495-200059040-00010
Pubmed ID
Authors

Anna J. Matheson, Stuart Noble

Abstract

Racecadotril is an oral enkephalinase inhibitor used in the treatment of acute diarrhoea. It prevents the degradation of endogenous opioids (enkephalins), thereby reducing hypersecretion of water and electrolytes into the intestinal lumen. In a randomised double-blind study in 6 adult volunteers with castor oil-induced diarrhoea, racecadotril significantly reduced stool weight and stool number in comparison with placebo. Similar results have been obtained in treating castor oil-induced diarrhoea in rats. Racecadotril was significantly more effective than placebo in randomised double-blind studies in adults or children with diarrhoea (of infectious origin or in adults with HIV infection). In well controlled trials, racecadotril had efficacy similar to that of loperamide and was generally as effective as loperamide-oxide. Racecadotril had a similar tolerability profile to placebo, and was better tolerated than loperamide, in adults and children with diarrhoea. It caused significantly less constipation after resolution of diarrhoea than loperamide.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Colombia 1 2%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 14%
Student > Postgraduate 7 12%
Student > Master 7 12%
Student > Ph. D. Student 6 10%
Student > Bachelor 4 7%
Other 6 10%
Unknown 20 34%
Readers by discipline Count As %
Medicine and Dentistry 18 31%
Pharmacology, Toxicology and Pharmaceutical Science 7 12%
Agricultural and Biological Sciences 3 5%
Mathematics 1 2%
Nursing and Health Professions 1 2%
Other 5 9%
Unknown 23 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2022.
All research outputs
#2,475,503
of 25,374,917 outputs
Outputs from Drugs
#282
of 3,464 outputs
Outputs of similar age
#22,630
of 286,193 outputs
Outputs of similar age from Drugs
#45
of 1,067 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,464 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,193 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 1,067 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.